Ferran Araujo-Ayala
@araujo_ferran
Post-doctoral lymphoma researcher at IDIBAPS
ID: 1606233073078702080
23-12-2022 10:19:50
39 Tweet
57 Followers
119 Following
Congratulations Judith Mateos-Jaimez and team for this amazing work! For sure it will be an incredible tool for onco-hematology research in primary samples.
🩸 El limfoma fol·licular és un tipus de càncer hematològic. Gràcies a l'impuls de #LaMarató3Cat, Patricia Pérez, de l'IDIBAPS - Hospital Clínic, investiga per millorar-ne el diagnòstic i tractament 📌 19 i 20 de març, IDIBAPS - Hospital Clínic 👉 visitesrecercamarato.tv3.cat/ca/93-web-indi…
🆕 The European @THERAVLINFO project led by #CLÍNIC- @IDIBAPS Barcelona is launched to advance personalised #lymphoma medicine This project is led by Patricia Perez Galan 👩🔬 👉 i.mtr.cool/psjlpyvddn
Our follicular lymphoma spheroids are finally out! In this study leaded by Patricia Perez Galan, Cèlia Dobaño and Juan Garcia Valero, we present a 3D model that mimics the FL-LN and discover Galectin-9 as a promising target for immunotherapy
Going back to Barcelona after this fantastic #AACRlymph24 meeting in Philly, where I got the chance to present our latest work. Thanks to Follicular Lymphoma Foundation and La Marató de 3Cat for supporting our research and AACR for providing me a travel award.
Exciting PhD Thesis Opportunity! We are seeking candidates for a PhD thesis at FRCB-IDIBAPS in the field of #Hematology. Application deadline:18/07/2024 Location: Barcelona (Spain) More information: clinicbarcelona.org/uploads/media/… Join our innovative research team! #POCTEFA #Interreg
CONGRESS | #ASH24 | PRESENTATION Ferran Araujo-Ayala of Institut D’Investigacions Biomèdiques August Pi I Sunyer discussed the prognosis potential of CD70 and its biological role in patients with FL and development of a novel dual CD19-CD70 CAR T-cell therapy for FL and B-NHL. Follow